4-p-Tolyloxy-benzylamine

(4-(4-chlorophenoxy)phenyl)methylamine hydrochloride is a pharmaceutical intermediate. It has been reported in the literature that it can be used to prepare an imidazo[1,2-a]pyridine derivative such as N-(4-(4-chlorophenoxy)benzyl)-2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamide, which can inhibit Mycobacterium tuberculosis.